C12N 2501/2325
Interleukin-25
Official title: Interleukin-25 (IL-25)
C12N2501/2325 (Interleukin-25) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 7
- Inventors
- 16
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 3 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for improving cognitive function14 Oct 2025US 12,440,513 B2Albany Medical College
- Human innate lymphoid cell precursors: identification, characterization, applications20 Jun 2023US 11,680,245 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Stable Tregs and related materials and methods28 Apr 2015US 9,018,006 B2The University of Toledo
- Methods for improving cognitive function2 Apr 2026US 2026/0091063 A1Albany Medical College
- Compositions and methods for producing and using ilcs to treat health conditions9 Nov 2023US 2023/0355675 A1
- Human innate lymphoid cell precursors: identification, characterization, applications12 Oct 2023US 2023/0323304 A1Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Method of producing tumor-reactive t cell composition using modulatory agents2 Feb 2023US 2023/0032934 A1Myst Therapeutics, LLC
- Methods for improving cognitive function28 Apr 2022US 2022/0125849 A1Albany Medical College
Most cited
By later US patents